16p11.2微缺失综合征是一类先天性基因缺失的疾病,其人群发生率约为万分之三。该综合征的临床表现包括自闭症、发育迟缓、智力低下、脊柱畸形等一系列神经精神发育疾病,患者间表型异质性明显,而其致病机制目前尚未明确。本文从16p11.2微缺失的类型、临床表型、致病机制、检测技术等方面综述其研究进展,以便更好地为16p11.2微缺失综合征的机制研究和临床诊治提供帮助。
16p11.2 microdeletion syndrome is one of the congential genetic diseases displaying autism, intellectual disability (ID), developmental delay (DD), spinal deformity and so on, the incidence of which is approximately three over ten thousand. The phenotypic heterogeneity is significant among patients, but the pathogenic mechanism underlying 16p11.2 microdeletion syndrome is still uncertain. Here, we review the types, clinical phenotypes, possible pathogenic mechanisms and detection technology of 16p11.2 microdeletion syndrome to provide some help for mechanistic study and clinical diagnosis and treatment.
傅冬梅,郭奇伟,周裕林. 16p11.2微缺失综合征的研究进展[J]. 国际遗传学杂志,2017,40(4):247-252.
DOI:10.3760/cma.j.issn.1673-4386.2017.04.012版权归中华医学会所有。
未经授权,不得转载、摘编本刊文章,不得使用本刊的版式设计。
除非特别声明,本刊刊出的所有文章不代表中华医学会和本刊编委会的观点。

你好,我可以帮助您更好的了解本文,请向我提问您关注的问题。